A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive prognostic markers. As a major component of tight junctions, claudins (CLDNs) presumably play an important role in carcinogenesis and progression of breast cancer. This study was aimed at determining the...
Main Authors: | Fei Ma, Xiaoyan Ding, Ying Fan, Jianming Ying, Shan Zheng, Ning Lu, Binghe Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4231092?pdf=render |
Similar Items
-
Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer
by: F. Piras, et al.
Published: (2011-11-01) -
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
by: Zi-Ming Zhao, et al.
Published: (2019-01-01) -
circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis
by: Jinling Yu MMed, et al.
Published: (2020-09-01) -
Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer.
by: Nicola Ferrari, et al.
Published: (2014-01-01) -
MAT2B expression correlates with poor prognosis in triple-negative breast cancer
by: Xu J, et al.
Published: (2019-06-01)